NURS5463 Exam2 (Latest Update )
Adult Gerontology Acute Care | Questions &
ANSwers | Grade A | 100% Correct
1. What is the treatment for bullous dermatoses? ANS Systemic
corticosteroids (prednisone).
2. What characterizes toxic epidermal necrolysis? ANS Similar to Stevens-
Johnson syndrome, affects less than 30% total body surface.
3. What is the management of hyperleukocytosis? ANS Emergency
chemotherapy, hydroxyurea, leukapheresis, correct coagulation, do not
transfuse RBC.
4. What characterizes hypoglycemia that doesn’t respond to glucagon? ANS
ETOH intoxication due to preventing the liver from releasing glucose.
5. What is the first-line treatment of VTE? ANS Apixaban (Factor Xa),
Rivaroxaban (Factor Xa), Edoxaban (Factor Xa), Dabigatran (thrombin).
6. What are the clinical findings with Cushing disease? ANS Obesity (moon
face, buffalo hump), weight gain on abdomen, facial plethora, abdominal
1
, striae, easy bruising, acne, difficulty wound healing, worsening hypertension,
diabetes mellitus, infection, muscle weakness, edema.
7. What is used to treat psoriatic urgencies? ANS Systemic medications
(methotrexate, acitretin, cyclosporine), no oral steroids.
8. What characterizes erysipelas? ANS Caused by streptococcus, erythema is
well demarcated, raised, often affects lower extremities and face, penicillin is
first-line treatment.
9. What is the insulin replacement protocol for DKA and HHS? ANS Bolus
0.15 units/kg, infuse 0.1 units/kg/hr. With DKA, change to subcutaneous once
anion gap is closed and patient is ready to eat; do not use urine ketone, use
beta-hydroxybutyrate.
10. What characterizes Stevens-Johnson syndrome? ANS Develops over 3 to
4 days, blister rash and erosions on face, trunk, limbs, and mucosal surfaces,
can cause organ damage, affects less than 10% total body surface.
11. What is the treatment for graft-versus-host disease (GVHD)? ANS Occurs
within 100 days (acute) or after 100 days (chronic), all patients receiving
2
Adult Gerontology Acute Care | Questions &
ANSwers | Grade A | 100% Correct
1. What is the treatment for bullous dermatoses? ANS Systemic
corticosteroids (prednisone).
2. What characterizes toxic epidermal necrolysis? ANS Similar to Stevens-
Johnson syndrome, affects less than 30% total body surface.
3. What is the management of hyperleukocytosis? ANS Emergency
chemotherapy, hydroxyurea, leukapheresis, correct coagulation, do not
transfuse RBC.
4. What characterizes hypoglycemia that doesn’t respond to glucagon? ANS
ETOH intoxication due to preventing the liver from releasing glucose.
5. What is the first-line treatment of VTE? ANS Apixaban (Factor Xa),
Rivaroxaban (Factor Xa), Edoxaban (Factor Xa), Dabigatran (thrombin).
6. What are the clinical findings with Cushing disease? ANS Obesity (moon
face, buffalo hump), weight gain on abdomen, facial plethora, abdominal
1
, striae, easy bruising, acne, difficulty wound healing, worsening hypertension,
diabetes mellitus, infection, muscle weakness, edema.
7. What is used to treat psoriatic urgencies? ANS Systemic medications
(methotrexate, acitretin, cyclosporine), no oral steroids.
8. What characterizes erysipelas? ANS Caused by streptococcus, erythema is
well demarcated, raised, often affects lower extremities and face, penicillin is
first-line treatment.
9. What is the insulin replacement protocol for DKA and HHS? ANS Bolus
0.15 units/kg, infuse 0.1 units/kg/hr. With DKA, change to subcutaneous once
anion gap is closed and patient is ready to eat; do not use urine ketone, use
beta-hydroxybutyrate.
10. What characterizes Stevens-Johnson syndrome? ANS Develops over 3 to
4 days, blister rash and erosions on face, trunk, limbs, and mucosal surfaces,
can cause organ damage, affects less than 10% total body surface.
11. What is the treatment for graft-versus-host disease (GVHD)? ANS Occurs
within 100 days (acute) or after 100 days (chronic), all patients receiving
2
